Targeting IL-12 family cytokines: A potential strategy for type 1 and type 2 diabetes mellitus
2023 · Biomedicine & Pharmacotherapy · 17 citations
https://doi.org/10.1016/j.biopha.2023.115958
T
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
45
Papers
1.4K
Citations
14
h-index
19
i10-index
Tao Jiang is an academic researcher from Genomics Institute of the Novartis Research Foundation. The author has contributed to research in topics: Bone health and osteoporosis research & HIV Research and Treatment & Liver Disease Diagnosis and Treatment. The author has an h-index of 14, co-authored 39 publications.
ORCID: 0000-0003-2081-1997Papers by this author
worksThe inhibition of PINK1/Drp1-mediated mitophagy by hyperglycemia leads to impaired osteoblastogenesis in diabetes
2024 · iScience · 6 citations
https://doi.org/10.1016/j.isci.2024.111519
Molecular mechanism of type ib MET inhibitors and their potential for CNS tumors
2025 · Scientific Reports · 3 citations
https://doi.org/10.1038/s41598-025-85631-w
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat